203 related articles for article (PubMed ID: 28508128)
1. The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study.
Ogata H; Kumasawa J; Fukuma S; Mizobuchi M; Kinugasa E; Fukagawa M; Fukuhara S; Akizawa T
Clin Exp Nephrol; 2017 Oct; 21(5):797-806. PubMed ID: 28508128
[TBL] [Abstract][Full Text] [Related]
2. Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study.
Yotsueda R; Taniguchi M; Tanaka S; Eriguchi M; Fujisaki K; Torisu K; Masutani K; Hirakata H; Kitazono T; Tsuruya K
Am J Kidney Dis; 2017 Jul; 70(1):84-92. PubMed ID: 28196648
[TBL] [Abstract][Full Text] [Related]
3. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients.
Okute Y; Shoji T; Hayashi T; Kuwamura Y; Sonoda M; Mori K; Shioi A; Tsujimoto Y; Tabata T; Emoto M; Inaba M
J Atheroscler Thromb; 2017 Apr; 24(4):412-421. PubMed ID: 27629255
[TBL] [Abstract][Full Text] [Related]
4. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.
Tentori F; Wang M; Bieber BA; Karaboyas A; Li Y; Jacobson SH; Andreucci VE; Fukagawa M; Frimat L; Mendelssohn DC; Port FK; Pisoni RL; Robinson BM
Clin J Am Soc Nephrol; 2015 Jan; 10(1):98-109. PubMed ID: 25516917
[TBL] [Abstract][Full Text] [Related]
5. Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study.
Arase H; Yamada S; Yotsueda R; Taniguchi M; Yoshida H; Tokumoto M; Nakano T; Tsuruya K; Kitazono T
Atherosclerosis; 2018 Aug; 275():115-123. PubMed ID: 29890446
[TBL] [Abstract][Full Text] [Related]
6. Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.
Soohoo M; Feng M; Obi Y; Streja E; Rhee CM; Lau WL; Wang J; Ravel VA; Brunelli S; Kovesdy CP; Kalantar-Zadeh K
Am J Nephrol; 2016; 43(2):85-96. PubMed ID: 26950688
[TBL] [Abstract][Full Text] [Related]
7. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
[TBL] [Abstract][Full Text] [Related]
8. Use of vitamin D receptor activator, incident cardiovascular disease and death in a cohort of hemodialysis patients.
Shoji T; Marubayashi S; Shigematsu T; Iseki K; Tsubakihara Y; ;
Ther Apher Dial; 2015 Jun; 19(3):235-44. PubMed ID: 25530222
[TBL] [Abstract][Full Text] [Related]
9. Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients.
Omae K; Ogawa T; Yoshikawa M; Nitta K
Heart Vessels; 2012 Nov; 27(6):610-7. PubMed ID: 21953505
[TBL] [Abstract][Full Text] [Related]
10. Association of serum chloride level with mortality and cardiovascular events in chronic kidney disease: the CKD-ROUTE study.
Mandai S; Kanda E; Iimori S; Naito S; Noda Y; Kikuchi H; Akazawa M; Oi K; Toda T; Sohara E; Okado T; Sasaki S; Rai T; Uchida S
Clin Exp Nephrol; 2017 Feb; 21(1):104-111. PubMed ID: 27039905
[TBL] [Abstract][Full Text] [Related]
11. Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5D.
Fukagawa M; Komaba H; Onishi Y; Fukuhara S; Akizawa T; Kurokawa K;
Am J Nephrol; 2011; 33(5):427-37. PubMed ID: 21508631
[TBL] [Abstract][Full Text] [Related]
12. Influence of chronic kidney disease on hospitalization, chronic dialysis, and mortality in Japanese men: a longitudinal analysis.
Nishikawa K; Takahashi K; Yamada R; Kinaga T; Masato M; Yamamoto M
Clin Exp Nephrol; 2017 Apr; 21(2):316-323. PubMed ID: 27339450
[TBL] [Abstract][Full Text] [Related]
13. Geriatric nutritional risk index accurately predicts cardiovascular mortality in incident hemodialysis patients.
Takahashi H; Ito Y; Ishii H; Aoyama T; Kamoi D; Kasuga H; Yasuda K; Maruyama S; Matsuo S; Murohara T; Yuzawa Y
J Cardiol; 2014 Jul; 64(1):32-6. PubMed ID: 24365385
[TBL] [Abstract][Full Text] [Related]
14. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
15. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
16. A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan.
Maruyama Y; Taniguchi M; Kazama JJ; Yokoyama K; Hosoya T; Yokoo T; Shigematsu T; Iseki K; Tsubakihara Y
Nephrol Dial Transplant; 2014 Aug; 29(8):1532-8. PubMed ID: 24642419
[TBL] [Abstract][Full Text] [Related]
17. CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.
Block GA; Kilpatrick RD; Lowe KA; Wang W; Danese MD
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2132-40. PubMed ID: 24052218
[TBL] [Abstract][Full Text] [Related]
18. Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.
Hayashi M; Abe T; Iwai M; Matsui A; Yoshida T; Sato Y; Kanno Y;
Clin Exp Nephrol; 2016 Oct; 20(5):787-794. PubMed ID: 26627501
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of B-type natriuretic peptide for estimating left atrial size and its usefulness for predicting all-cause mortality and cardiovascular events among chronic haemodialysis patients.
Ishigami J; Iimori S; Kuwahara M; Sasaki S; Tsukamoto Y
Nephrology (Carlton); 2014 Dec; 19(12):777-83. PubMed ID: 25142830
[TBL] [Abstract][Full Text] [Related]
20. Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients.
Merle E; Roth H; London GM; Jean G; Hannedouche T; Bouchet JL; Drüeke T; Fouque D; Daugas E;
Kidney Int; 2016 Mar; 89(3):666-74. PubMed ID: 26880460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
